328 related articles for article (PubMed ID: 37746079)
1. Role of sphingosine 1-phosphate (S1P) in sepsis-associated intestinal injury.
Sun G; Wang B; Zhu H; Ye J; Liu X
Front Med (Lausanne); 2023; 10():1265398. PubMed ID: 37746079
[TBL] [Abstract][Full Text] [Related]
2. The role of sphingosine-1-phosphate in the gut mucosal microenvironment and inflammatory bowel diseases.
Zou F; Wang S; Xu M; Wu Z; Deng F
Front Physiol; 2023; 14():1235656. PubMed ID: 37560160
[TBL] [Abstract][Full Text] [Related]
3. Unveiling the biological role of sphingosine-1-phosphate receptor modulators in inflammatory bowel diseases.
Tourkochristou E; Mouzaki A; Triantos C
World J Gastroenterol; 2023 Jan; 29(1):110-125. PubMed ID: 36683721
[TBL] [Abstract][Full Text] [Related]
4. Barrier maintenance by S1P during inflammation and sepsis.
Ziegler AC; Gräler MH
Tissue Barriers; 2021 Oct; 9(4):1940069. PubMed ID: 34152926
[TBL] [Abstract][Full Text] [Related]
5. Endothelial Sphingosine-1-Phosphate Receptor 4 Regulates Blood-Brain Barrier Permeability and Promotes a Homeostatic Endothelial Phenotype.
Hansen L; Lohfink N; Vutukuri R; Kestner RI; Trautmann S; Hecht M; Wagner PV; Spitzer D; Khel MI; Macas J; Ferreirós N; Gurke R; Günther S; Pfeilschifter W; Devraj K
J Neurosci; 2022 Mar; 42(10):1908-1929. PubMed ID: 34903569
[TBL] [Abstract][Full Text] [Related]
6. Review article: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis - a unique therapeutic target in inflammatory bowel disease.
Wang J; Goren I; Yang B; Lin S; Li J; Elias M; Fiocchi C; Rieder F
Aliment Pharmacol Ther; 2022 Feb; 55(3):277-291. PubMed ID: 34932238
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1 phosphate promotes intestinal epithelial cell proliferation via S1PR2.
Chen T; Huang Z; Liu R; Yang J; Hylemon PB; Zhou H
Front Biosci (Landmark Ed); 2017 Jan; 22(4):596-608. PubMed ID: 27814635
[TBL] [Abstract][Full Text] [Related]
8. Role of sphingosine-1-phosphate receptors in vascular injury of inflammatory bowel disease.
Wang X; Chen S; Xiang H; Liang Z; Lu H
J Cell Mol Med; 2021 Mar; 25(6):2740-2749. PubMed ID: 33595873
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease.
Sukocheva OA; Lukina E; McGowan E; Bishayee A
Adv Protein Chem Struct Biol; 2020; 120():123-158. PubMed ID: 32085881
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential.
Aoki M; Aoki H; Ramanathan R; Hait NC; Takabe K
Mediators Inflamm; 2016; 2016():8606878. PubMed ID: 26966342
[TBL] [Abstract][Full Text] [Related]
11. Signaling through the S1P-S1PR Axis in the Gut, the Immune and the Central Nervous System in Multiple Sclerosis: Implication for Pathogenesis and Treatment.
Chatzikonstantinou S; Poulidou V; Arnaoutoglou M; Kazis D; Heliopoulos I; Grigoriadis N; Boziki M
Cells; 2021 Nov; 10(11):. PubMed ID: 34831439
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases.
Burg N; Salmon JE; Hla T
Nat Rev Rheumatol; 2022 Jun; 18(6):335-351. PubMed ID: 35508810
[TBL] [Abstract][Full Text] [Related]
13. The Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis in Intestinal Epithelial Cells Regulates Intestinal Barrier Function During Intestinal Epithelial Cells-CD4+T-Cell Interactions.
Chen T; Lin R; Jin S; Chen R; Xue H; Ye H; Huang Z
Cell Physiol Biochem; 2018; 48(3):1188-1200. PubMed ID: 30045015
[TBL] [Abstract][Full Text] [Related]
14. Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis.
Pérez-Jeldres T; Alvarez-Lobos M; Rivera-Nieves J
Drugs; 2021 Jun; 81(9):985-1002. PubMed ID: 33983615
[TBL] [Abstract][Full Text] [Related]
15. Hyperglycemia-Triggered Sphingosine-1-Phosphate and Sphingosine-1-Phosphate Receptor 3 Signaling Worsens Liver Ischemia/Reperfusion Injury by Regulating M1/M2 Polarization.
Hu Y; Yang C; Shen G; Yang S; Cheng X; Cheng F; Rao J; Wang X
Liver Transpl; 2019 Jul; 25(7):1074-1090. PubMed ID: 30972941
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of sphingosine 1-phosphate receptor signalling in cancer.
Patmanathan SN; Wang W; Yap LF; Herr DR; Paterson IC
Cell Signal; 2017 Jun; 34():66-75. PubMed ID: 28302566
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.
Sukocheva OA; Furuya H; Ng ML; Friedemann M; Menschikowski M; Tarasov VV; Chubarev VN; Klochkov SG; Neganova ME; Mangoni AA; Aliev G; Bishayee A
Pharmacol Ther; 2020 Mar; 207():107464. PubMed ID: 31863815
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine-1-Phosphate Receptor Type 4 (S1P
Riese J; Gromann A; Lührs F; Kleinwort A; Schulze T
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801658
[TBL] [Abstract][Full Text] [Related]
19. A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury.
Ueda N
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409370
[TBL] [Abstract][Full Text] [Related]
20. S1pping fire: Sphingosine-1-phosphate signaling as an emerging target in inflammatory bowel disease and colitis-associated cancer.
Degagné E; Saba JD
Clin Exp Gastroenterol; 2014; 7():205-14. PubMed ID: 25061328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
